Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-041729
Filing Date
2023-04-04
Accepted
2023-04-04 20:03:10
Documents
2
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2311710-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2311710-4_4seq1.xml 4 6266
2 EXHIBIT 24 tm2311710d4_ex24.htm EX-24 8675
  Complete submission text file 0001104659-23-041729.txt   16506
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address
Gassert Chad (Reporting) CIK: 0001871002 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 23800690